| Michael D Elder, MD | |
|
4317 W Memorial Rd, Oklahoma City, OK 73134-1720 | |
| (405) 755-6240 | |
| Not Available |
| Full Name | Michael D Elder |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 4317 W Memorial Rd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255375762 | NPI | - | NPPES |
| 100106980A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 14210 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael D Elder, MD Po Box 5733, Edmond, OK 73083-5733 Ph: (405) 775-9350 | Michael D Elder, MD 4317 W Memorial Rd, Oklahoma City, OK 73134-1720 Ph: (405) 755-6240 |
News Archive
New guidelines developed by the American Cancer Society recommend that screening for colorectal cancer for average-risk adults begin at age 45, five years earlier than the previous recommendation.
"It is in poor countries and communities, where health needs are greatest and physicians are scarce, that nurses take an even greater role in health care delivery, often serving as the sole providers in rural villages or urban slums," Sheila Davis, director of global nursing at Partners In Health, writes in a Huffington Post "Impact Blog" opinion piece, noting this is International Nurses Week.
A theoretical technique developed at the Department of Energy's Oak Ridge National Laboratory is bringing supercomputer simulations and experimental results closer together by identifying common "fingerprints."
ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee voted 7-1 that a validated test to identify the T315I mutation should be reviewed by the FDA prior to approval of OMAPRO™ (omacetaxine mepesuccinate).
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced today that a Phase 2 study (ARC001) evaluating the company's lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively.
› Verified 4 days ago
Dr. Elizabeth Anne Williams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6201 Beaver Creek Rd, Oklahoma City, OK 73162 Phone: 405-210-4198 Fax: 405-703-7595 | |
Dr. Steven J Lantier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9500 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-475-0680 | |
Dr. Martin J Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4525 S Klein Ave, Ste 900, Oklahoma City, OK 73109 Phone: 405-636-1797 | |
Betty J Haywood, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 750 Ne 13th St, Oac 200, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 | |
Dr. Suhal S Mahid, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Lee Ave, Oklahoma City, OK 73102 Phone: 405-272-8000 | |
Dr. Lauren L. Fitzgerald, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 918-392-2944 Fax: 918-664-2521 | |
Sathish Ramanathan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 |